HEWES L. BECKER (Chief Medical Officer) received a stock award from DAMORA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/7/2026ACC: 0001193125-26-006723
Officer· Chief Medical Officer
Since Jan 2026
+793.23K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
793.23K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+264.63K
Price / share
—
Trade value
—
% of position
New position
1/5/2026
0.00→264.63K
Total
Net shares
+264.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | A · Award | +264.63K | — | — | New position | 0.00 | 264.63K |
| Total | +264.63K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
528.60K shares
Shares
+528.60K
Strike price
21.82
Held after
528.60K
Exercisable
—
1/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock528.60K shares | 1/5/2026 | A · Award | +528.60K | 21.82 | — | 528.60K |